» Articles » PMID: 1913655

Prognostic Significance of Argyrophilic Nucleolar Organizer Regions in Esophageal Carcinoma

Overview
Journal Cancer Res
Specialty Oncology
Date 1991 Oct 1
PMID 1913655
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The argyrophilic nucleolar organizer region (AgNOR) of 100 cancer cells from biopsy specimens of esophageal squamous cell carcinomas in 98 surgically treated cases was examined, using a silver colloid staining technique on biopsy specimens. The number of AgNOR per nucleus (AgNOR number) was higher in the more advanced groups with regard to the length of the tumor (P less than 0.01), the depth of penetration (P less than 0.05), and lymph node metastasis (P less than 0.01). The survival of the patients with a high AgNOR number (greater than or equal to 6) was significantly poorer than those with either a medium range AgNOR number (4 less than or equal to-less than 6) (P less than 0.05) or a low AgNOR number (less than 4) (P less than 0.01). In the multivariate analysis including conventional clinicopathological factors, the AgNOR number was found to be one of the independent and significant variables (P less than 0.01). Because the AgNOR method is simple and can be applied to paraffin-embedded sections, the AgNOR number may provide potential benefit in the pretherapeutic assessment of malignant potentiality in esophageal carcinoma.

Citing Articles

Argyrophilic nucleolar organizer regions as a prognostic indicator of laryngeal carcinomas.

Nakashima T, Yano G, Masuda A, Uemura T, Morita M Eur Arch Otorhinolaryngol. 1994; 251 Suppl 1:S76-9.

PMID: 11894783 DOI: 10.1007/BF02565226.


Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy.

Shimada Y, Imamura M, Shibagaki I, Tanaka H, Miyahara T, Kato M Ann Surg. 1997; 226(2):162-8.

PMID: 9296509 PMC: 1190950. DOI: 10.1097/00000658-199708000-00007.


Predictive value of argyrophilic nucleolar-organizer-region-associated proteins in bladder cancer, using cell-imprint preparations.

Masuda M, Takano Y, Iki M, Jinza S, Noguchi S, Kubota Y J Cancer Res Clin Oncol. 1997; 123(1):1-5.

PMID: 8996533 DOI: 10.1007/BF01212607.


p53 accumulation in colorectal cancer with hepatic metastasis.

Maruyama K, Tanaka T, Baba S, Nakamura S, Endo Y, Sugimura H Jpn J Cancer Res. 1996; 87(4):368-76.

PMID: 8641968 PMC: 5921109. DOI: 10.1111/j.1349-7006.1996.tb00232.x.


Gallbladder cancer. A comparative study among clinicopathologic features, AgNORs, and DNA content analysis.

Ayabe H, Hatano K, Yamaguchi H, Tagawa Y Dig Dis Sci. 1996; 41(5):840-7.

PMID: 8625752 DOI: 10.1007/BF02091520.